MLH1 and neoplasm: In in vivo experiments, stiripentol markedly inhibited the expression of H3K9la and LUC7L2, but promoted that of MLH1, and combination therapy with stiripentol and TMZ dramatically decreased tumor growth and substantially prolonged the survival of mice.